Literature DB >> 17213233

Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease.

Ming-Chang Chiang1, Hui-Mei Chen, Yi-Hsin Lee, Hao-Hung Chang, Yi-Chih Wu, Bing-Wen Soong, Chiung-Mei Chen, Yih-Ru Wu, Chin-San Liu, Dau-Ming Niu, Jer-Yuarn Wu, Yuan-Tsong Chen, Yijuang Chern.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. Using two mouse models of HD, we demonstrate that the urea cycle deficiency characterized by hyperammonemia, high blood citrulline and suppression of urea cycle enzymes is a prominent feature of HD. The resultant ammonia toxicity might exacerbate the neurological deficits of HD. Suppression of C/EBPalpha, a crucial transcription factor for the transcription of urea cycle enzymes, appears to mediate the urea cycle deficiency in HD. We found that in the presence of mutant Htt, C/EBPalpha loses its ability to interact with an important cofactor (CREB-binding protein). Moreover, mutant Htt recruited C/EBPalpha into aggregates, as well as suppressed expression of the C/EBPalpha gene. Consumption of protein-restricted diets not only led to the restoration of C/EBPalpha's activity, and repair of the urea cycle deficiency and hyperammonemia, but also ameliorated the formation of Htt aggregates, the motor deterioration, the suppression of striatal brain-derived neurotrophic factor and the normalization of three protein chaperones (Hsp27, Hsp70 and Hsp90). Treatments aimed at repairing the urea cycle deficiency may provide a new strategy for dealing with HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213233     DOI: 10.1093/hmg/ddl481

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  36 in total

Review 1.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

Review 2.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

3.  Mass spectrometric identification of novel lysine acetylation sites in huntingtin.

Authors:  Xin Cong; Jason M Held; Francesco DeGiacomo; Akilah Bonner; Jan Marie Chen; Birgit Schilling; Gregg A Czerwieniec; Bradford W Gibson; Lisa M Ellerby
Journal:  Mol Cell Proteomics       Date:  2011-06-18       Impact factor: 5.911

4.  Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.

Authors:  Renee R Handley; Suzanne J Reid; Rudiger Brauning; Paul Maclean; Emily R Mears; Imche Fourie; Stefano Patassini; Garth J S Cooper; Skye R Rudiger; Clive J McLaughlan; Paul J Verma; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

5.  Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.

Authors:  Huanhuan Luo; Liying Cao; Xuan Liang; Ana Du; Ting Peng; He Li
Journal:  Mol Neurobiol       Date:  2018-02-12       Impact factor: 5.590

6.  Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.

Authors:  B Blairanne Williams; Gunnar F Kwakye; Michal Wegrzynowicz; Daphne Li; Michael Aschner; Keith M Erikson; Aaron B Bowman
Journal:  Toxicol Sci       Date:  2010-06-13       Impact factor: 4.849

7.  Restricted transgene expression in the brain with cell-type specific neuronal promoters.

Authors:  Aurélie Delzor; Noelle Dufour; Fanny Petit; Martine Guillermier; Diane Houitte; Gwennaelle Auregan; Emmanuel Brouillet; Philippe Hantraye; Nicole Déglon
Journal:  Hum Gene Ther Methods       Date:  2012-08-30       Impact factor: 2.396

8.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

9.  Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.

Authors:  Wen-Chuan Shen; Huei-Ying Li; Guang-Chao Chen; Yijuang Chern; Pang-Hsien Tu
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

10.  Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalus.

Authors:  Ming-Jen Lee; Ching-Pang Chang; Yi-Hsin Lee; Yi-Chih Wu; Hsu-Wen Tseng; Yu-Ying Tung; Min-Tzu Wu; Yen-Hui Chen; Lu-Ting Kuo; Dennis Stephenson; Shuen-Iu Hung; Jer-Yuarn Wu; Chen Chang; Yuan-Tsong Chen; Yijuang Chern
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.